MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Scribe Therapeutics, Inc. (SCTX)

Scribe Therapeutics, Inc. (SCTX)

||
||

Balance Sheets Overview

Current Ratio
57.31%
Quick Ratio
57.31%
Cash Ratio
45.22%
Debt to Asset Ratio
176.80%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated depreciation an...
    • Short-term investments
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Redeemable convertible preferred...
    • Convertible note
    • Others
Balance Sheets
2026-06-30
Cash and cash equivalents
35,586
Short-term investments
7,423
Receivable from collaboration partners
1,107
Prepaid expenses and other current assets
989
Total current assets
45,105
Operating lease right-of-use asset
2,782
Total
17,946
Less accumulated depreciation and amortization
12,191
Property and equipment, net
5,755
Restricted cash
675
Other long-term assets
3,610
Total assets
57,927
Accounts payable
2,771
Accrued expenses and other current liabilities
7,183
Accrued license fees
2,100
Deferred revenue, current
27,475
Convertible note
37,799
Operating lease liabilities, current portion
1,369
Total current liabilities
78,697
Operating lease liabilities, net of current portion
4,102
Other non-current liabilities
7,920
Deferred revenue, non-current
11,698
Total liabilities
102,417
Redeemable convertible preferred stock, 0.001 par value 29,182,118 shares authorized, and 4,915,299 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively liquidation preference of 120,705 as of june 30, 2026 and december 31, 2025
120,356
Common stock, 0.001 par value, 52,000,000 shares authorized as of june 30, 2026 and december 31, 2025 2,485,234 and 2,451,167 shares issued and outstanding as of june 30, 2026 and december 31, 2025
14
Additional paid-in capital
16,673
Accumulated deficit
-181,531
Accumulated other comprehensive income
-2
Total stockholders' deficit
-164,846
Total liabilities, preferred stock, and stockholders' deficit
57,927
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$35,586K Short-term investments$7,423K Receivable fromcollaboration partners$1,107K Prepaid expenses andother current assets$989K Total$17,946K Total current assets$45,105K Property and equipment,net$5,755K Other long-termassets$3,610K Operating leaseright-of-use asset$2,782K Restricted cash$675K Less accumulateddepreciation and...$12,191K Total assets$57,927K Accumulated deficit-$181,531K Accumulated othercomprehensive income-$2K Total liabilities,preferred stock, and...$57,927K Total stockholders'deficit-$164,846K Additional paid-in capital$16,673K Common stock, 0.001 parvalue, 52,000,000...$14K Redeemable convertiblepreferred stock, 0.001 par...$120,356K Total liabilities$102,417K Total currentliabilities$78,697K Deferred revenue,non-current$11,698K Other non-currentliabilities$7,920K Operating leaseliabilities, net of current...$4,102K Convertible note$37,799K Deferred revenue,current$27,475K Accrued expenses andother current...$7,183K Accounts payable$2,771K Accrued license fees$2,100K Operating leaseliabilities, current portion$1,369K